The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
// STATE LEGISLATION TRACKER

Missouri HB 2285: Abolishes abortion in the state.

โš–๏ธ NEUTRAL for peptide users ๐Ÿ‘ค NONE user impact ๐Ÿ“œ Status: Failed
State
Missouri
Bill
HB 2285
Filed
2020-01-28
Read the bill
OpenStates โ†’
Last reviewed
2026-10-02

Plain-English Summary

Missouri HB2285 was an abortion-focused bill from the 2020 session. Based on the title, subject, and available status information, it does not appear to regulate compounded peptides, off-label prescribing, telehealth, NP/naturopath scope, FDA 503A/503B compounding, controlled substances, or prescription monitoring.

Key Points

  • No apparent effect on peptide access or prescribing
  • No apparent change to compounding rules
  • No apparent telehealth or scope-of-practice change
  • Not a controlled-substance or PDMP bill

What to Watch For

i
Note This appears to be outside the peptide-policy ecosystem unless later text added unrelated health care provisions.
i
Note Clinicians should treat it as reproductive-health legislation, not peptide or compounding legislation.

Where the Bill Stands

The bill was introduced in 2020 and died in committee after referral to the House Children and Families Committee.
ยท Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 ยท enriched via codex gpt-5.5
Source: OpenStates v3 API ยท View official bill ยท โ† back to all laws